These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
368 related articles for article (PubMed ID: 27995392)
1. Abnormal Barrier Function in Gastrointestinal Disorders. Farré R; Vicario M Handb Exp Pharmacol; 2017; 239():193-217. PubMed ID: 27995392 [TBL] [Abstract][Full Text] [Related]
2. Tight junctions and IBS--the link between epithelial permeability, low-grade inflammation, and symptom generation? Piche T Neurogastroenterol Motil; 2014 Mar; 26(3):296-302. PubMed ID: 24548256 [TBL] [Abstract][Full Text] [Related]
3. Mucosal pathobiology and molecular signature of epithelial barrier dysfunction in the small intestine in irritable bowel syndrome. González-Castro AM; Martínez C; Salvo-Romero E; Fortea M; Pardo-Camacho C; Pérez-Berezo T; Alonso-Cotoner C; Santos J; Vicario M J Gastroenterol Hepatol; 2017 Jan; 32(1):53-63. PubMed ID: 27087165 [TBL] [Abstract][Full Text] [Related]
4. Disruption of the epithelial barrier during intestinal inflammation: Quest for new molecules and mechanisms. Lechuga S; Ivanov AI Biochim Biophys Acta Mol Cell Res; 2017 Jul; 1864(7):1183-1194. PubMed ID: 28322932 [TBL] [Abstract][Full Text] [Related]
6. Mucosal permeability and immune activation as potential therapeutic targets of probiotics in irritable bowel syndrome. Barbara G; Zecchi L; Barbaro R; Cremon C; Bellacosa L; Marcellini M; De Giorgio R; Corinaldesi R; Stanghellini V J Clin Gastroenterol; 2012 Oct; 46 Suppl():S52-5. PubMed ID: 22955358 [TBL] [Abstract][Full Text] [Related]
7. Enteric Pathogens and Their Toxin-Induced Disruption of the Intestinal Barrier through Alteration of Tight Junctions in Chickens. Awad WA; Hess C; Hess M Toxins (Basel); 2017 Feb; 9(2):. PubMed ID: 28208612 [TBL] [Abstract][Full Text] [Related]
8. Impaired duodenal mucosal integrity and low-grade inflammation in functional dyspepsia. Vanheel H; Vicario M; Vanuytsel T; Van Oudenhove L; Martinez C; Keita ÅV; Pardon N; Santos J; Söderholm JD; Tack J; Farré R Gut; 2014 Feb; 63(2):262-71. PubMed ID: 23474421 [TBL] [Abstract][Full Text] [Related]
9. Gastrointestinal mucosal barrier function and diseases. Oshima T; Miwa H J Gastroenterol; 2016 Aug; 51(8):768-78. PubMed ID: 27048502 [TBL] [Abstract][Full Text] [Related]
10. Irritable bowel syndrome: methods, mechanisms, and pathophysiology. The confluence of increased permeability, inflammation, and pain in irritable bowel syndrome. Camilleri M; Lasch K; Zhou W Am J Physiol Gastrointest Liver Physiol; 2012 Oct; 303(7):G775-85. PubMed ID: 22837345 [TBL] [Abstract][Full Text] [Related]
11. Ex Vivo Intestinal Sacs to Assess Mucosal Permeability in Models of Gastrointestinal Disease. Mateer SW; Cardona J; Marks E; Goggin BJ; Hua S; Keely S J Vis Exp; 2016 Feb; (108):e53250. PubMed ID: 26891144 [TBL] [Abstract][Full Text] [Related]
12. Diarrhoea-predominant irritable bowel syndrome: an organic disorder with structural abnormalities in the jejunal epithelial barrier. Martínez C; Lobo B; Pigrau M; Ramos L; González-Castro AM; Alonso C; Guilarte M; Guilá M; de Torres I; Azpiroz F; Santos J; Vicario M Gut; 2013 Aug; 62(8):1160-8. PubMed ID: 22637702 [TBL] [Abstract][Full Text] [Related]
13. Intestinal permeability defects: is it time to treat? Odenwald MA; Turner JR Clin Gastroenterol Hepatol; 2013 Sep; 11(9):1075-83. PubMed ID: 23851019 [TBL] [Abstract][Full Text] [Related]
14. Intestinal permeability in children with recurrent respiratory and gastrointestinal symptoms. Barreto M; Evangelisti M; Principessa L; Simmaco M; Negro V; Lionetto L; Campisano M; Villa MP J Paediatr Child Health; 2015 Dec; 51(12):1214-20. PubMed ID: 26044914 [TBL] [Abstract][Full Text] [Related]
15. Intestinal mucosal barrier function in health and disease. Turner JR Nat Rev Immunol; 2009 Nov; 9(11):799-809. PubMed ID: 19855405 [TBL] [Abstract][Full Text] [Related]
16. From clinical uncertainties to precision medicine: the emerging role of the gut barrier and microbiome in small bowel functional diseases. Marlicz W; Yung DE; Skonieczna-Żydecka K; Loniewski I; van Hemert S; Loniewska B; Koulaouzidis A Expert Rev Gastroenterol Hepatol; 2017 Oct; 11(10):961-978. PubMed ID: 28618973 [TBL] [Abstract][Full Text] [Related]
17. Immune dysregulation in the functional gastrointestinal disorders. Keely S; Walker MM; Marks E; Talley NJ Eur J Clin Invest; 2015 Dec; 45(12):1350-9. PubMed ID: 26444549 [TBL] [Abstract][Full Text] [Related]
18. Mucosal permeability and mast cells as targets for functional gastrointestinal disorders. Keita ÅV; Söderholm JD Curr Opin Pharmacol; 2018 Dec; 43():66-71. PubMed ID: 30216901 [TBL] [Abstract][Full Text] [Related]
19. Butyrate modifies intestinal barrier function in IPEC-J2 cells through a selective upregulation of tight junction proteins and activation of the Akt signaling pathway. Yan H; Ajuwon KM PLoS One; 2017; 12(6):e0179586. PubMed ID: 28654658 [TBL] [Abstract][Full Text] [Related]
20. Functional bowel symptoms in quiescent inflammatory bowel diseases: role of epithelial barrier disruption and low-grade inflammation. Vivinus-Nébot M; Frin-Mathy G; Bzioueche H; Dainese R; Bernard G; Anty R; Filippi J; Saint-Paul MC; Tulic MK; Verhasselt V; Hébuterne X; Piche T Gut; 2014 May; 63(5):744-52. PubMed ID: 23878165 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]